Advertisement

Topics

Poor NOAC Adherence in AF Wreaks Havoc on Efficacy vs Warfarin

07:33 EDT 17 May 2018 | Medscape

Benefits of novel oral anticoagulants that wowed in clinical trials may not carry over into clinical practice, when adherence to prescribed therapy usually declines, suggests an observational analysis.
Medscape Medical News

Original Article: Poor NOAC Adherence in AF Wreaks Havoc on Efficacy vs Warfarin

NEXT ARTICLE

More From BioPortfolio on "Poor NOAC Adherence in AF Wreaks Havoc on Efficacy vs Warfarin"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...